{"nct_id":"NCT02598297","title":"Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.","status":"TERMINATED","status_verified_date":"2019-07","start_date":"2016-02-03","start_date_type":"ACTUAL","primary_completion_date":"2017-10-23","primary_completion_date_type":"ACTUAL","completion_date":"2017-10-23","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}